Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

Overview of attention for article published in BMC Cancer, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 9,587 followers.

RT @LaurenSchaffMD: Officially published! Low-dose glucarpidase is effective for MTX clearance, even after multiple administrations. Glucar…

RT @LaurenSchaffMD: Officially published! Low-dose glucarpidase is effective for MTX clearance, even after multiple administrations. Glucar…

RT @LaurenSchaffMD: Officially published! Low-dose glucarpidase is effective for MTX clearance, even after multiple administrations. Glucar…

RT @LaurenSchaffMD: Officially published! Low-dose glucarpidase is effective for MTX clearance, even after multiple administrations. Glucar…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.